Display Settings:

Format

Send to:

Choose Destination
    Pharmacol Rep. 2009 Mar-Apr;61(2):197-216.

    Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.

    Source

    Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, PL 20-090 Lublin, Poland. jarogniew.luszczki@am.lublin.pl

    Abstract

    This review briefly summarizes the information on the molecular mechanisms of action, pharmacokinetic profiles and drug interactions of novel (third-generation) antiepileptic drugs, including brivaracetam, carabersat, carisbamate, DP-valproic acid, eslicarbazepine, fluorofelbamate, fosphenytoin, ganaxolone, lacosamide, losigamone, pregabalin, remacemide, retigabine, rufinamide, safinamide, seletracetam, soretolide, stiripentol, talampanel, and valrocemide. These novel antiepileptic drugs undergo intensive clinical investigations to assess their efficacy and usefulness in the treatment of patients with refractory epilepsy.

    PMID:
    19443931
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Institute of Pharmacology Polish Academy of Sciences

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk